Drewe E - Search Results

1

Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome.

Simon A, Drewe E, van der Meer JW, Powell RJ, Kelley RI, Stalenhoef AF, Drenth JP. Simon A, et al. Among authors: drewe e. Clin Pharmacol Ther. 2004 May;75(5):476-83. doi: 10.1016/j.clpt.2004.01.012. Clin Pharmacol Ther. 2004. PMID: 15116060 Clinical Trial.

2

Role of interleukin-6 in a patient with tumor necrosis factor receptor-associated periodic syndrome: assessment of outcomes following treatment with the anti-interleukin-6 receptor monoclonal antibody tocilizumab.

Vaitla PM, Radford PM, Tighe PJ, Powell RJ, McDermott EM, Todd I, Drewe E. Vaitla PM, et al. Among authors: drewe e. Arthritis Rheum. 2011 Apr;63(4):1151-5. doi: 10.1002/art.30215. Arthritis Rheum. 2011. PMID: 21225679 Free article.

3

Treatment of the nephrotic syndrome with etanercept in patients with the tumor necrosis factor receptor-associated periodic syndrome.

Drewe E, McDermott EM, Powell RJ. Drewe E, et al. N Engl J Med. 2000 Oct 5;343(14):1044-5. doi: 10.1056/NEJM200010053431412. N Engl J Med. 2000. PMID: 11023397 No abstract available.

4

The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder.

Hull KM, Drewe E, Aksentijevich I, Singh HK, Wong K, McDermott EM, Dean J, Powell RJ, Kastner DL. Hull KM, et al. Among authors: drewe e. Medicine (Baltimore). 2002 Sep;81(5):349-68. doi: 10.1097/00005792-200209000-00002. Medicine (Baltimore). 2002. PMID: 12352631 Free article. Review.

5

Clinically useful monoclonal antibodies in treatment.

Drewe E, Powell RJ. Drewe E, et al. J Clin Pathol. 2002 Feb;55(2):81-5. doi: 10.1136/jcp.55.2.81. J Clin Pathol. 2002. PMID: 11864998 Free PMC article. Review.

6

Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patients.

Drewe E, McDermott EM, Powell PT, Isaacs JD, Powell RJ. Drewe E, et al. Rheumatology (Oxford). 2003 Feb;42(2):235-9. doi: 10.1093/rheumatology/keg070. Rheumatology (Oxford). 2003. PMID: 12595616

7

Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndrome.

Drewe E, Huggins ML, Morgan AG, Cassidy MJ, Powell RJ. Drewe E, et al. Rheumatology (Oxford). 2004 Nov;43(11):1405-8. doi: 10.1093/rheumatology/keh357. Epub 2004 Aug 17. Rheumatology (Oxford). 2004. PMID: 15316120

8

Comment on: Failure of anti-TNF therapy in TNF receptor 1-associated periodic syndrome (TRAPS).

Drewe E, Powell RJ, McDermott EM. Drewe E, et al. Rheumatology (Oxford). 2007 Dec;46(12):1865-6. doi: 10.1093/rheumatology/kem231. Epub 2007 Oct 29. Rheumatology (Oxford). 2007. PMID: 17967816 No abstract available.

9

Etanercept AL amyloidosis.

Drewe E, Powell RJ. Drewe E, et al. Lancet. 2001 Sep 1;358(9283):761. doi: 10.1016/S0140-6736(01)05913-X. Lancet. 2001. PMID: 11556345 No abstract available.

10

Emerging clinical spectrum of tumor necrosis factor receptor-associated periodic syndrome: comment on the articles by Hull et al and Dodé et al.

Drewe E, Lanyon PC, Powell RJ. Drewe E, et al. Arthritis Rheum. 2003 Jun;48(6):1768-9; author reply 1769-70. doi: 10.1002/art.10981. Arthritis Rheum. 2003. PMID: 12794852 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters